Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.6K
Overview
43.6K
Cancer Vaccines01:30

Cancer Vaccines

324
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
324
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Hybridoma Technology01:31

Hybridoma Technology

14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.

JHEP reports : innovation in hepatology·2026
Same author

Isochlorogenic acid A impairs hepatitis B virus replication by interference with various steps of hepatitis B virus life cycle involving HO-1-mediated ROS modulation.

Antiviral research·2025
Same author

Comparative analysis of a flexible novel vaccine platform based on cell permeable chimeric HBV capsids for mucosal vaccination.

Vaccine·2025
Same author

Generation and Characterization of HDV-Specific Antisera with Respect to Their Application as Specific and Sensitive Research and Diagnostic Tools.

Viruses·2025
Same author

Cell line-dependent release of quasi-enveloped hepatitis E virus reveals alternative Golgi-associated egress in the absence of pORF3.

Frontiers in cellular and infection microbiology·2025
Same author

The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis.

Viruses·2025
Same journal

[The progress of participation research. A sociological analysis of its institutionalization].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.1K

[Platform technologies in vaccine development].

Eberhard Hildt1

  • 1Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen (Hessen), Deutschland. eberhard.hildt@pei.de.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|March 4, 2025
PubMed
Summary
This summary is machine-generated.

Vaccine development platforms offer rapid adaptation for new pathogens. Approved vaccines utilize viral vectors and mRNA encapsulated in lipid nanoparticles for enhanced delivery and protection.

Keywords:
NanoparticlesPlatform technologyVaccineViral vectorsmRNA

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.5K

Related Experiment Videos

Last Updated: May 24, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.5K

Area of Science:

  • Vaccinology and biotechnology
  • Molecular and cellular biology

Context:

  • Platform technologies enable rapid vaccine development against emerging infectious diseases.
  • Current EU-approved vaccines leverage viral vectors (e.g., adenoviruses, VSV, MVA) and messenger RNA (mRNA) as core platforms.

Purpose:

  • To outline the principles and advantages of platform technologies in vaccine development.
  • To describe the mechanisms of viral vector and mRNA-based vaccine platforms.

Summary:

  • Platform technologies utilize a consistent vaccine framework, differing only in antigen, allowing swift adaptation for novel pathogens or variants.
  • Viral vectors like recombinant adenoviruses (Ad), vesicular stomatitis virus (VSV), and modified vaccinia virus Ankara (MVA) are employed.
  • Messenger RNA (mRNA) vaccines are delivered via lipid nanoparticles (LNPs), which protect mRNA, facilitate cellular uptake, and offer adjuvant effects.

Impact:

  • Accelerated response to public health threats through adaptable vaccine design.
  • Enhanced vaccine efficacy and delivery mechanisms via innovative platform approaches.